Editors’ page

Código QR

Editors’ page

Guardado en:

Detalles Bibliográficos
Autores principales:	Erin D. Michos, Nathan D. Wong
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Diseases of the circulatory (Cardiovascular) system RC666-701 Public aspects of medicine RA1-1270
Acceso en línea:	https://doaj.org/article/f1bd949a7e924cd1962d76177bcfb481
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Title page
Publicado: (2021)

INTERVENTIONS TO MITIGATE CARDIOVASCULAR DISEASE RISK AFTER ADVERSE PREGNANCY OUTCOMES: A REVIEW
por: Amanda R. Jowell, et al.
Publicado: (2021)

Shared decision making and patient reported outcomes among adults with atherosclerotic cardiovascular disease, medical expenditure panel survey 2006–2015
por: Victor Okunrintemi, et al.
Publicado: (2021)

Secondary Prevention of Cardiovascular Disease in Women: Closing the Gap
por: Aarti Thakkar, et al.
Publicado: (2021)

Editorial Board Page
Publicado: (2021)

Income disparity and utilization of cardiovascular preventive care services among U.S. adults
por: Andi Shahu, et al.
Publicado: (2021)

WHAT DRIVES PRIMARY CARE PROVIDERS TO SCREEN WOMEN VETERANS FOR CARDIOVASCULAR RISKS WITH COMPETING DEMANDS AND LIMITED TIME? PATIENT FACTORS ASSOCIATED WITH TEMPLATE USE IN THE VA
por: Bevanne Bean-Mayberry, et al.
Publicado: (2021)

Association between diet quality and incident cardiovascular disease stratified by body mass index
por: Nathan W. Kong, et al.
Publicado: (2021)

INCREASING STATIN USE IN DIABETICS FOR CVD PREVENTION
por: Karsh Gaurav, et al.
Publicado: (2021)

PROPORTION OF PSORIASIS IN FAMILIAL HYPERCHOLESTEROLEMIA
por: Samip Sheth, et al.
Publicado: (2021)

GENDER DOES NOT SIGNIFICANTLY MODULATE FASTING PLASMA GLUCOSE IMPROVEMENTS WITH LIFESTYLE INTERVENTION IN PREDIABETES PARTICIPANTS WITH VERSUS WITHOUT A FAMILY HISTORY OF DIABETES
por: Karen S. George, et al.
Publicado: (2021)

ASPIRIN FOR CARDIOVASCULAR DISEASE PREVENTION AMONG ADULTS IN THE UNITED STATES: TRENDS, PREVALENCE, AND PARTICIPANT CHARACTERISTICS ASSOCIATED WITH USE
por: Ellen Boakye, et al.
Publicado: (2021)

Heart healthy diet: A modifiable tool for cardiovascular disease prevention
por: Rama Hritani
Publicado: (2021)

DISPARITIES AMONG RACE AND GENDER IN SUSTAINED ACHIEVEMENT OF GOAL LIPID LEVELS AFTER ACUTE CORONARY SYNDROME
por: Maxwell Ambrosino, et al.
Publicado: (2021)

“DO NOT RESUSCITATE” ORDERS AMONG HOSPITALIZED PATIENTS WITH COVID-19: EVALUATING PREVENTIVE ETHICS REGARDING CARDIOPULMONARY RESUSCITATION
por: Johnathan Kirupakaran, et al.
Publicado: (2021)

IMPROVING PRIMARY CARE AWARENESS AND SCREENING OF ADULTS WITH FAMILIAL HYPERCHOLESTEROLEMIA THROUGH AN ONLINE PROVIDER EDUCATIONAL PROGRAM
por: Mary Nametka, et al.
Publicado: (2021)

NOVEL TIERED HEART FAILURE STAGING, RISK, AND SOCIAL DETERMINANTS OF HEALTH OF AN URBAN COMMUNITY CLINIC BEFORE AND DURING COVID-19
por: Melvin R. Echols, et al.
Publicado: (2021)

LIVRQNac (AXA1125) ENHANCES INSULIN SENSITIVITY IN PRIMARY HUMAN HEPATOCYTES AND IN SUBJECTS WITH NAFLD AND T2D
por: Seth J. Baum, et al.
Publicado: (2021)

ARE THERE DIFFERENCES IN STATIN PRESCRIBING PRACTICES BASED ON PROVIDER AND PATIENT GENDERS? A RETROSPECTIVE, QUANTITATIVE AND QUALITATIVE CHART REVIEW
por: Payton Skawinski, et al.
Publicado: (2021)

SERUM COPPER AND THE RISK OF CVD MORTALITY IN NORMAL WEIGHT, PRE-OBESE AND OBESE MEN IN FINLAND
por: Nzechukwu M. Isiozor, et al.
Publicado: (2021)

PERFORMANCE OF EXISTING CARDIOVASCULAR RISK ASSESSMENT TOOLS IN SUB-SAHARAN AFRICA: A SYSTEMATIC REVIEW
por: Yousif M. Hydoub, et al.
Publicado: (2021)

DISPARITIES AMONG GENDER AND RACIAL GROUPS IN THE USE OF GUIDELINE DIRECTED HYPERLIPIDEMIA MANAGEMENT IN PATIENTS PRESENTING WITH ACUTE CORONARY SYNDROME
por: Maxwell Ambrosino, et al.
Publicado: (2021)

SUCCESSFUL PIVOT OF A COMMUNITY EXERCISE PROGRAM TO VIRTUAL DURING THE COVID-19 PANDEMIC
por: LeTracia Rose, et al.
Publicado: (2021)

ESTIMATED AGGREGATE TREATMENT BENEFIT WITH ADDITION OF MULTIPLE NOVEL MEDICATIONS FOR SECONDARY PREVENTION OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE
por: Robert W. Ariss, et al.
Publicado: (2021)

Table of Contents
Publicado: (2021)

Editorial Board
Publicado: (2021)

INTERNAL MEDICINE RESIDENT EDUCATION AND THE IMPACT ON CARDIAC REHABILITATION REFERRAL RATES IN AN AMBULATORY CARE SETTING: A PILOT STUDY
por: Maggie Wang, et al.
Publicado: (2021)

CLINICAL PROFILE AND OUTCOMES OF HOSPITALIZED PATIENTS WITH COVID-19 AND CARDIOMETABOLIC RISK FACTORS IN BROOKLYN, NEW YORK
por: Johnathan Kirupakaran, et al.
Publicado: (2021)

DETECTING HYPERTENSION AND IMPROVING HEALTHY LIFESTYLE IN AFRICAN AMERICAN WOMEN ATTENDING COMMUNITY SCREENING PROGRAM
por: Waddah Malas, et al.
Publicado: (2021)

Agricultural policy and societal factors influence patients’ ability to follow a healthy diet
por: Gautam Ramesh, et al.
Publicado: (2021)

Association of Hypertension and Diabetes with Ischemic Heart Disease and Stroke Mortality in India: The Million Death Study
por: Calvin Ke, et al.
Publicado: (2021)

Letter to the Editor: Multimodality imaging of a left ventricular mass
por: Guljan Abakirova
Publicado: (2021)

Answer to Letter to the Editor: Multimodality imaging of a left ventricular mass
por: Sergey Yakovlev
Publicado: (2021)

The impact of lipid-lowering medications on coronary artery plaque characteristics
por: Vishnu Priya Pulipati, et al.
Publicado: (2021)

Maximising Opportunities Post Coronavirus Disease 2019: Time to Embrace a New Era of Atrial Fibrillation Research
por: Pier D Lambiase
Publicado: (2021)

The Dilemma of Peri-Procedural Warfarin Management: A Narrative Review
por: Islam Eljilany MSc, et al.
Publicado: (2021)

What is Standard Dose of Rivaroxaban in Elderly Asian Patients with Atrial Fibrillation: 20ms versus. 15mg?
por: Sung Soo Kim MD, et al.
Publicado: (2021)

Cardiovascular and Renal Risk Factors and Complications Associated With COVID-19
por: Rhian M. Touyz, MBBCh, PhD, et al.
Publicado: (2021)

Oral Anticoagulant and Antiplatelet Therapy for Cervical Artery Dissection: A Meta-Analysis of Clinical Trials
por: Sheng-Lin Ye MD, et al.
Publicado: (2021)

Current Evidence and Future Directions of PCSK9 Inhibition
por: Jiaqian Xu, et al.
Publicado: (2021)